Functional Imaging of SDHx-Related Head and Neck Paragangliomas: Comparison of 18F-Fluorodihydroxyphenylalanine, 18F-Fluorodopamine, 18F-Fluoro-2-Deoxy-D-Glucose PET, 123I-Metaiodobenzylguanidine Scintigraphy, and 111In-Pentetreotide Scintigraphy

被引:98
作者
King, Kathryn S.
Chen, Clara C. [2 ]
Alexopoulos, Dimitrios K. [3 ]
Whatley, Millie A. [2 ]
Reynolds, James C. [2 ]
Patronas, Nicholas [3 ]
Ling, Alexander [3 ]
Adams, Karen T.
Xekouki, Paraskevi [2 ,4 ]
Lando, Howard [5 ]
Stratakis, Constantine A. [2 ,4 ]
Pacak, Karel [1 ]
机构
[1] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Sect Med Neuroendocrinol, Reprod & Adult Endocrinol Program, Bethesda, MD 20892 USA
[2] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Sect Endocrinol & Genet, Program Dev Endocrinol & Genet,Nucl Med Div,Dept, Bethesda, MD 20892 USA
[3] NIH, Ctr Clin, Dept Radiol & Imaging Sci, Bethesda, MD 20892 USA
[4] NIH, Pediat Endocrinol Inter Inst Training Program, Bethesda, MD 20892 USA
[5] Med Specialists No Virginia, Alexandria, VA 22306 USA
基金
美国国家卫生研究院;
关键词
POSITRON-EMISSION-TOMOGRAPHY; MALIGNANT PHEOCHROMOCYTOMA; I-123-MIBG SCINTIGRAPHY; OCTREOTIDE SCINTIGRAPHY; METAIODOBENZYLGUANIDINE; DIAGNOSIS; SUPERIOR; BENIGN; TUMORS; LOCALIZATION;
D O I
10.1210/jc.2011-0333
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Accurate diagnosis of head and neck paragangliomas is often complicated by biochemical silence and lack of catecholamine-associated symptoms, making accurate anatomical and functional imaging techniques essential to the diagnostic process. Methods: Ten patients (seven SDHD, three SDHB), with a total of 26 head and neck paragangliomas, were evaluated with anatomical and functional imaging. This study compares five different functional imaging techniques [F-18-fluorodihydroxyphenylalanine (F-18-FDOPA) positron emission tomography (PET), F-18-fluorodopamine (F-18-FDA) PET/computed tomography (CT), F-18-fluoro-2-deoxy-D-glucose (F-18-FDG) PET/CT, I-123-metaiodobenzylguanidine (I-123-MIBG) scintigraphy, and In-111-pentetreotide scintigraphy] in the localization of head and neck paragangliomas. Results: Prospectively F-18-FDOPA PET localized 26 of 26 lesions in the 10 patients, CT/magnetic resonance imaging localized 21 of 26 lesions, F-18-FDG PET/CT localized 20 of 26 lesions, (111)-Inpentetreotide scintigraphy localized 16 of 25 lesions, F-18-FDA PET/CT localized 12 of 26 lesions, and 123I-MIBG scintigraphy localized eight of 26 lesions. Differences in imaging efficacy related to genetic phenotype, even in the present small sample size, included the negativity of 18F-FDA PET/CT and 123I-MIBG scintigraphy in patients with SDHB mutations and the accuracy of 18F-FDG PET/CT in all patients with SDHD mutations, as compared with the accuracy of 18F-FDG PET/CT in only one patient with an SDHB mutation. Conclusion: Overall, F-18-FDOPA PET proved to be the most efficacious functional imaging modality in the localization of SDHx-related head and neck paragangliomas and may be a potential first-line functional imaging agent for the localization of these tumors. (J Clin Endocrinol Metab 96: 2779-2785, 2011)
引用
收藏
页码:2779 / 2785
页数:7
相关论文
共 39 条
[11]   New imaging approaches to phaeochromocytomas and paragangliomas [J].
Havekes, Bas ;
King, Kathryn ;
Lai, Edwin W. ;
Romijn, Johannes A. ;
Corssmit, Eleonora P. M. ;
Pacak, Karel .
CLINICAL ENDOCRINOLOGY, 2010, 72 (02) :137-145
[12]   18F-DOPA positron emission tomography for the detection of glomus tumours [J].
Hoegerle, S ;
Ghanem, N ;
Altehoefer, C ;
Schipper, J ;
Brink, I ;
Moser, E ;
Neumann, HPH .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (05) :689-694
[13]   Pheochromocytomas:: Detection with 18F DOPA whole-body PET -: Initial results [J].
Hoegerle, S ;
Nitzsche, E ;
Altehoefer, C ;
Ghanem, N ;
Manz, T ;
Brink, I ;
Reincke, M ;
Moser, E ;
Neumann, HPH .
RADIOLOGY, 2002, 222 (02) :507-512
[14]   Comparison of 6-18 F-Fluorodopamine PET with 123I-Metaiodobenzylguanidine and 111In-Pentetreotide Scintigraphy in Localization of Nonmetastatic and Metastatic Pheochromocytoma [J].
Ilias, Ioannis ;
Chen, Clara C. ;
Carrasquillo, Jorge A. ;
Whatley, Millie ;
Ling, Alexander ;
Lazurova, Ivica ;
Adams, Karen T. ;
Perera, Shiromi ;
Pacak, Karel .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (10) :1613-1619
[15]   Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors [J].
Kaltsas, G ;
Korbonits, M ;
Heintz, E ;
Mukherjee, JJ ;
Jenkins, PJ ;
Chew, SL ;
Reznek, R ;
Monson, JP ;
Besser, GM ;
Foley, R ;
Britton, KE ;
Grossman, AB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) :895-902
[16]   18F-fluorodeoxyglucose PET/CT in cancer imaging [J].
Kayani, Irfan ;
Groves, Ashley M. .
CLINICAL MEDICINE, 2006, 6 (03) :240-244
[17]   111In-octreotide is superior to 123I-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas [J].
Koopmans, Klaas Pieter ;
Jager, Pieter L. ;
Kema, Ido P. ;
Kersten, Michiel N. ;
Albers, Frans ;
Dullaart, Robin P. F. .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (08) :1232-1237
[18]  
KRENNING EP, 1992, J NUCL MED, V33, P652
[19]  
KWEKKEBOOM DJ, 1993, J NUCL MED, V34, P873
[20]  
LINNOILA RI, 1990, HUM PATHOL, V21, P1168